Hereditary Prostate Cancer: Clinical Trials

3 trials for Hereditary Prostate Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow Hereditary Prostate Cancer: new trials by email Literature Review of Hereditary Prostate Cancer trials Research Report on Hereditary Prostate Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations
Targeted Prostate Cancer Screening, Telephone Follow-Up Interview - Prostate Cancer, Hereditary Prostate Cancer
Not applicableCompletedInstitute of Oncology Ljubljana252021-03-292026-02-18
Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a
Genetic Risk Score: Number Format, Genetic Risk Score: Number + Pictograph, Family History: Number Format - Prostate Cancer, Prostate Cancer, Familial
Not applicableCompletedEndeavor Health7002011-06-012019-11-22
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
DNA analysis, polymorphism analysis, laboratory biomarker analysis - Hereditary Prostate Cancer, Prostate Cancer
CompletedPortland VA Medical Center7482008-07-012021-11-11

Narrower conditions

Prostate cancer, familial (3)  ·  Prostatic Neoplasms (3)  ·  Genetic Predisposition to Disease (1)

Broader conditions

Genital Diseases (3)  ·  Genital Diseases, Male (3)  ·  Genital Neoplasms, Male (3)  ·  Male Urogenital Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Prostatic Diseases (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Disease Attributes (1)  ·  Disease Susceptibility (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Amplified Fragment Length Polymorphism Analysis (1)

Sponsors

Endeavor Health (1)  ·  Institute of Oncology Ljubljana (1)  ·  Portland VA Medical Center (1)

Countries

Slovenia (1)  ·  United States (1)

Top investigators

Jackilen Shannon, PhD (1)  ·  Jianfeng Xu, Dr.P.H. (1)

NIH funding

1RC2CA148463-01 (1)